Tenir en attendant le vaccin…

Tenir en attendant le vaccin…

le-marche-du-lundi

Après le consortium Pfizer-BioNTech, c’est au tour de Moderna d’annoncer un vaccin, basé sur la technologie de l’« ARN messager », avec un taux d’efficacité de près de 95%. Même si ces deux vaccins expérimentaux reçoivent (rapidement) l’approbation de l’agence américaine du médicament (FDA), il faudra s’armer de beaucoup de patience avant que l’activité retrouve sa dynamique « pré-Covid19 ». En effet, la multiplication des périodes de confinement et des mesures sanitaires pèsent sur les perspectives d’activité qui demeurent, à court terme, incertaines.

Lire la suite

Responsabilité: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Let's block ads! (Why?)